OVERVIEW

Advances In Supportive Care: An Onco-Nurses Guide to Managing Cancer Treatment-Related Toxicities is organized by Physicians' Education Resource LLC (PER) and will be held from Jun 29, 2018 - Jun 29, 2019.

The target audience for this medical event is directed toward nurses and other healthcare professionals who treat patients with cancer. This CME Conference has been approved for a maximum of 1.5 Credits.

Description:
This activity, Advances In Supportive Care: An Onco-Nurses Guide to Managing Cancer Treatment- Related Toxicities, will highlight best practices in the supportive care management of a broad range of treatment-related toxicities that you can apply in the care of your patients with cancer. Some of these toxicities, such as hematologic deficiencies and chemotherapy-induced nausea and vomiting, are common across most tumor types, whereas others, such as tumor lysis syndrome and methotrexate toxicity, occur primarily in patients with certain types of cancer. The nurse practitioners serving as our faculty will discuss the frequency, risk factors, symptoms, and management of these toxicities. Additional focus will be placed on selected clinical studies supporting the use of certain drugs to manage these toxicities, as well as guidelines that aim to recommend the optimal management strategies for your patients who encounter these toxicities.

Learning Objectives:
At the conclusion of this activity, you should be better prepared to:
• Describe the impact and occurrence of cancer-related morbidity related to use of chemotherapy, including chemotoxicity, chemotherapy-induced nausea and vomiting, venous thromboembolism, hematologic deficiencies, and anorexia-cachexia.
• Discuss emerging clinical trial data and evidence-based recommendations on supportive care strategies as they apply to the management of cancer-related morbidity and treatment-related toxicities.
• Apply clinical practice guidelines in the context of specific patient cases to optimize supportive care to optimize patient awareness, appropriate monitoring, and optimal management of treatment-related adverse events in at-risk patients.
• Optimize multidisciplinary supportive care strategies in the total oncologic care of patients with solid tumors and hematologic malignancies through patient counseling, education, and a caring approach.